Local preview using the live theme CSS. Header and footer omitted. Yellow = placeholder to replace.
IRCE > Grants > SECURE-Nigeria > AEFI

SECURE-Nigeria: AEFI

← SECURE-Nigeria overview
On this page
Completed SECURE-Nigeria sub-project

COVID-19 Vaccine Safety Surveillance (AEFI)

When people are vaccinated, any health problem that follows, whether or not the vaccine caused it, must be reported and reviewed. SECURE-Nigeria helped Nigeria bring these reports together so that COVID-19 vaccine safety could be monitored as a whole.

An adverse event following immunisation (AEFI) is any health problem that happens after a vaccination. It may be caused by the vaccine or may be a coincidence, such as malaria that happens to start soon after. Recording and investigating these events is how countries confirm that vaccines are safe and detect rare problems early.

As Nigeria rolled out COVID-19 vaccines in 2021, these reports were collected through several separate channels. Between April 2021 and June 2022, the United States Centers for Disease Control and Prevention (US CDC) and partners led by the Institute of Human Virology Nigeria (IHVN) supported the Government of Nigeria to combine and compare them. The work was done with the National Primary Health Care Development Agency (NPHCDA), the National Agency for Food and Drug Administration and Control (NAFDAC), the National Emergency Routine Immunization Coordination Centre and the National Expert Committee on AEFI.

IHVN led the combining of the data, its central management and the dashboard, with the University of Maryland, Baltimore developing the technical back end. Vaccine safety later became a dedicated area of DAVT, NCDC’s data analysis platform.

21,389Reports of health problems after COVID‑19 vaccination recorded and reviewed in five states
Under 1%Of these reports were classified as serious (fewer than 1 in 100)
5States supported
3Separate reporting streams brought together: individual case lists, a telephone call-in system and DHIS2

The challenge

Reports of health problems after COVID-19 vaccination were spread across a telephone call-in system, individual case lists, DHIS2 (the national health information system used by NPHCDA) and the MedSafety app used by NAFDAC. These systems did not share data, so decision-makers had no single, complete view of COVID-19 vaccine safety.

Next: What we did →

What we did

Mapped how reports travelled

Traced how reports moved from vaccination sites to national level, and engaged the people responsible for each reporting stream.

Brought the data together

Built a data management system that received and stored every shared dataset in one place.

Built a vaccine safety dashboard

Created an online dashboard with indicators based on World Health Organization and national guidance. It was deployed to the national COVID-19 vaccination technical working group in July 2022.

Connected the national systems

Brought the call-in, line list, DHIS2 and MedSafety reports together in the vaccine safety area of DAVT, where users can view the triangulated data or any single source. See data triangulation in DAVT.

Evaluated the reporting system

Evaluated how well the DHIS2 COVID-19 vaccine safety reporting system worked, and shared the findings with NPHCDA, NAFDAC and partners in Abuja in May 2025.

Supported expert review of serious cases

Contributed data expertise to the National Expert Committee on AEFI when it reviewed serious cases reported after Nigeria’s 2025 measles and rubella vaccination campaign.

Next: Results →

Results

A complete picture of COVID-19 vaccine safety

21,389 reports of health problems after COVID-19 vaccination were recorded and reviewed across five states. Fewer than 1 in 100 were classified as serious.

Systems that work together

One dashboard brings together reporting systems held by NPHCDA and NAFDAC for national decision-makers.

A clear next step

The expert review showed the need for one national digital tool that captures full case investigation forms and hospital notes, not just summary lists, so experts can judge whether a vaccine caused an event.

Next: Resources and sources →

Publications

  • Shragai T, Adegoke OJ, Ikwe H, Sorungbe T, Haruna A, Williams I, Okonkwo R, Onu K, Asekun A, Gberikon M, Iwara E, Abimiku A, et al. Implementation of data triangulation and dashboard development for COVID-19 vaccine adverse event following immunisation (AEFI) data in Nigeria. BMJ Global Health. 2023;8(1):e011006. doi:10.1136/bmjgh-2022-011006

Sources

Explore more IRCE research